TGTX · earnings call history
TG Therapeutics Q2 FY26 — Strong BRIUMVI Performance and Pipeline Advancement
Read the briefTG Therapeutics Q1 FY26 — Record BRIUMVI Revenue and Pipeline Advancement
Read the briefTG Therapeutics Q4 FY25 — BRIUMVI Drives Strong Growth, Pipeline Advances
Read the briefBrowse all US companies on the earnings-call register.